Inhibitory effect of a fullerene derivative, monomalonic acid C60, on nitric oxide-dependent relaxation of aortic smooth muscle

General Pharmacology

Volumn 29, Issue 3, 1997, Pages 345-351

  Satoh, Mitsutoshi ^a   Matsuo, Kazuhiro ^a   Kiriya, Hitoshi ^a   Mashino, Tadahiko ^b   Hirobe, Masaaki ^b   Takayanagi, Issei ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endothelium; Monomalonic acid C60 (MMA C60); Nitric oxide (NO); Smooth muscle; Superoxide dismutase (SOD)

Indexed keywords

ACETYLCHOLINE; FULLERENE DERIVATIVE; MALONIC ACID DERIVATIVE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; AORTA, THORACIC; CARBON; ENDOTHELIUM, VASCULAR; FULLERENES; GUINEA PIGS; HISTAMINE; MALE; MALONATES; MUSCLE RELAXATION; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; PHENYLEPHRINE; RABBITS; RATS; TRACHEA; VASODILATOR AGENTS;

EID: 0030864175     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00516-2     Document Type: Article

References (40)

1. 60. Science 253, 301-303.
2. 60. J. Phys. Chem. 95, 11-12.
3. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
4. Bennett B. M., McDonald B. J., Nigam R., Long P. G. and Simon W. C. (1992) Inhibition of nitrosodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin. Can. J. Physiol. Pharmac. 70, 1297-1303.
5. Boutorine A. S., Tokuyama H., Takasugi M., Isobe H., Nakamura E. and Helene C. (1994) Fullerene-oligonucleotide conjugates: photoinduced sequence-specific DNA cleavage. Angew. Chem. Int. Ed. Engl. 33, 2462-2465.
6. Crack P. and Cocks T. (1992) Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery. Br. J. Pharmacol. 107, 566-572.
7. Enokibori M., Okamura T. and Toda N. (1994) Mechanism underlying substance P-induced relaxation in dog isolated superficial temporal arteries. Br. J. Pharmac. 111, 77-82.
8. Furchgott R. F. (1983) Role of endothelium in responses of vascular smooth muscle. Circ. Res. 53, 557-573.
9. Furchgott R. F. and Zawadzki J. V. (1980) The obligatory role of endothelial calls in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
10. Gruetter C. A., Barry B. K., McNamara D. B., Gruetter D. Y., Kadowitz P. J. and Ignarro L. (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic Nucleo. Res. 5, 211-224.
11. Gryglewski R. J., Palmer R. M. and Moncada S. (1986) Super oxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320, 454-456.
12. 60 and di(ethoxy-carbonyl) methylene. Chem. Int. Ed. Engl. 33, 437-438.
13. 60 by photoacoustic calorimetry. J. Phys. Chem. 95, 6073-6075.
14. Ignarro L. J., Lippton H., Edwards J. C., Baricos W. H., Hyman A. L., Kadowitz P. J. and Gruetter C. A. (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmac. Exp. Ther. 218, 739-749.
15. Koike K., Takayanagi I., Wani S., Yanagita T., Ohta S. and Hirobe M. (1989) Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens. Gen. Pharmac. 20(2), 259-260.
16. Kowaluk E. A. and Fung H. L. (1990) Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmac. Exp. Ther. 255, 1256-1264.
17. Kowaluk E. A., Poliszczuk R. and Fung H. L. (1987) Tolerance to relaxation in rat aorta: comparison of an S-nitrosothiol with nitroglycerin. Eur. J. Pharmac. 144, 379-383.
18. 60: a new form of carbon. Nature 347, 354-358.
19. 60 : Buckministerfullerene. Nature 318, 162-163.
20. 60 with a defined three-dimensional structure. J. Chem. Soc. Chem. Commun. 1727-1728.
21. Marietta M. A. (1993) Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268, 12,231-12,234.
22. Mian K. B. and Martin W. (1995) Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by super oxide anion in rat aorta. Br. J. Pharmac. 115, 993-1000.
23. Moncada S., Palmer R. M. J. and Gryglewski R. J. (1986) Mechanism of action of some inhibitors of endothelium-derived factor. Proc. Natl. Acad. Scci. USA 83, 9164-9168.
24. Mulsch A. and Busse R. (1990) Nω-Nitro-L-arginine(N5-[imino(nitroamino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn-Schmiedeberg's Arch. Pharmac. 341, 143-147.
25. 60 with other photosensitizers, based on 1268 nm emission. Chem. Pharm. Bull. 42, 2291-2294.
26. Nakajima-Yamakoshi Y., Yagami T., Fukuhara K., Sueyoshi S. and Miyata N. (1994) Solubilization of fullerenes into water with polyvinylpyrrolidone applicable to biological tests. J. Chem. Soc. Chem. Commun. 517-518.
27. Palmer R. M. J., Rees D. D., Ashton D. S. and Moncada S. (1988) L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153, 1251-1256.
28. Palmer R. M. J., Ferrige A. G. and Moncada S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
29. Pettibone D. J., Clineschmidt B. V., Anderson P. S., Freidinger R. M., Lundell G. F., Koupal L. R., Schwart C. D., Williamson J. M., Goetz M. A., Hensens O. D., Liesch J. M. and Pringer S. J. P. ( 1989) A structurally unique, potent and selective oxytocin antagonist derived from Streptomyces silvensis. Endocrinology 125, 217-221.
30. G-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity. Br. J. Pharmac. 104, 743-749.
31. Rubanyi G. M. snd Vanhoutte P. M. (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250, H822-H827.
32. 60 on agonists-induced responses in various tissues of guinea-pig and rat. Gen. Pharmac. 26, 1533-1538.
33. Sijbesma R., Srdanov G., Castoro J. A., Wilkins C., Friedman S. H., DeCamp D. L. and Kenyon G. L. (1993) Synthesis of fullerene derivative for the inhibition of HIV enzymes. J. Am. Chem. Soc. 115, 6510-6512.
34. 60 in organic solvents. J. Org. Chem. 57, 6077-6079.
35. Takagi K. and Takayanagi I. (1958) Chemico-pharmacological studies on antispasmodic action XV: non-specific antispamodic action on trachea. Chem. Pharm. Bull. 6, 716-720.
36. 60. J. Phys. Chem. 95, 9080-9085.
37. Tokuyama H., Yamago S. and Nakamura E. (1993) Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115, 7918-7919.
38. Van Rossum J. M. (1963) Cumulative dose-response curve II: techniques of making of dose-response curves in isolated organs and evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther. 143, 299-330.
39. Waterfield A. A. and Kosterlitz H. K. (1975) In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu. Rev. Pharmac. 15, 27-29.
40. Zembowicz A., Hatchett R. J., Jakubowski A. M. and Gryglewski R. J. (1993) Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta. Br. J. Pharmac. 110, 151-158.